| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | CLG 3 ELISA Kit; CLG3 ELISA Kit; Collagenase 3 ELISA Kit; Collagenase3 ELISA Kit; MANDP1 ELISA Kit; Matrix metallopeptidase 13 (collagenase 3) ELISA Kit; Matrix Metalloproteinase 13 ELISA Kit; Matrix metalloproteinase-13 ELISA Kit; MMP 13 ELISA Kit; MMP-13 ELISA Kit; Mmp13 ELISA Kit; MMP13_HUMAN ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, cell culture supernates, urine, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Matrix metalloproteinase 13 (MMP13) is a biological molecule commonly studied in cancer research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P45452
Biological context
Researchers often monitor Matrix metalloproteinase 13 in serum, cell culture supernates, urine, and tissue homogenates to better understand themes such as tumor microenvironment biology, cell proliferation and apoptosis, and metastasis and invasion pathways. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Matrix metalloproteinase 13 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cell-cycle regulators, invasion/ECM markers, and immune-oncology mediators) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Matrix metalloproteinase 13 may also appear under names such as CLG 3 and CLG3. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Matrix metalloproteinase 13 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Combined detection of serum EFNA1 and MMP13 as diagnostic biomarker for gastric cancer
LY Chu,Scientific reports,2024
Abnormal kynurenine level contributes to the pathological bone features of ankylosing spondylitis
C Jeon,International immunopharmacology,2023
The role of miR-320a and IL-1B in human chondrocyte degradation
Y. Jin.et al,BONE JOINT RES,2017
Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing
Shan Xing.et al,Journal of Cancer 2,2017
Identification of Cathepsin K in the Peritoneal Metastasis of Ovarian Carcinoma Using In-silico, Gene Expression Analysis
Haiming Xu.et al,Journal of Cancer,2016
The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
Duncan HF. et al,J Cell Physiol,2015
Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13
Kim KS et al ,Rheumatology International,2012
Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis
Kim KS et al,Rheumatology International,2011
Increased levels of thymosin ß4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin ß4 with other factors that are involved in inflammation and bone erosion in joints
Hyun M. CHOI et al,International Journal of Rheumatic Diseases,2011